Sonoma Pharmaceuticals SNOA
NASDAQ SNOA
$1.11 -0.04 (-3.48%)
As of: Oct 23, 2026 · 2:58 PM EDT

Sonoma Pharmaceuticals (SNOA) Return on Sales [ROS] (2010 - 2026)

Updated

Sonoma Pharmaceuticals' Return on Sales [ROS] came in at -0.62% for fiscal Q1 2027 (quarter ended Jun 30, 2026), up 26.65 percentage points from -27.27% a year earlier and up 5.69 percentage points from the prior quarter.

Analysis

Sonoma Pharmaceuticals (SNOA) Return on Sales [ROS] (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Sonoma Pharmaceuticals reported Return on Sales [ROS] of -6.41%, up 17.94 percentage points year-over-year; for FY2026 (ended Mar 31, 2026), it was -12.60%, up 13.36 percentage points from FY2025.

  • Return on Sales [ROS] carries a five-year change of +5.91 percentage points (FY2021 to FY2026).
  • Going back by fiscal year, Return on Sales [ROS] was -25.97% in FY2025 (+10.95 pp), -36.91% in FY2024 (-2.48 pp), -34.43% in FY2023 (+12.19 pp) and -46.62% in FY2022 (-28.10 pp).
  • The fiscal Q1 2027 figure represents the highest quarterly Return on Sales [ROS] since fiscal Q2 2021.
  • Year-over-year, Return on Sales [ROS] has increased for six consecutive quarters, with an average year-over-year change of +14.77 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Sales [ROS] over five years came in fiscal Q4 2023 (a gain of 95.10 percentage points), and the weakest in fiscal Q3 2022 (a drop of 30.22 percentage points).
  • Business Quant data shows SNOA's Return on Sales [ROS] at -6.31% (Q4 2026), -15.59% (Q3 2026) and -6.01% (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Thermo Fisher Scientific 249.15 Bn 228.18 Bn 4.88 Bn 17.40%
2 Abbott Laboratories 180.74 Bn 151.17 Bn 7.27 Bn 13.44%
3 Danaher 161.29 Bn 145.10 Bn 3.61 Bn 17.99%
4 Intuitive Surgical 157.97 Bn 138.26 Bn 2.08 Bn 19.44%
5 Medtronic 122.53 Bn 87.79 Bn 6.34 Bn 18.08%
6 Stryker 118.24 Bn 104.35 Bn 4.50 Bn 25.18%
7 Boston Scientific 67.21 Bn 61.98 Bn 3.85 Bn 21.65%
8 Becton Dickinson 54.78 Bn 51.93 Bn 2.32 Bn 13.31%
9 Edwards Lifesciences 51.53 Bn 35.54 Bn 1.35 Bn 29.48%
10 Sonoma Pharmaceuticals 4.27 Mn -9.06 Mn 2.58 Mn -0.62%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.62%
Mar 31, 2026 -6.31%
Dec 31, 2025 -15.59%
Sep 30, 2025 -6.01%
Jun 30, 2025 -27.27%
Mar 31, 2025 -17.47%
Dec 31, 2024 -28.93%
Sep 30, 2024 -23.75%
Jun 30, 2024 -34.59%
Mar 31, 2024 -40.97%
Dec 31, 2023 -26.90%
Sep 30, 2023 -44.23%
Jun 30, 2023 -36.18%
Mar 31, 2023 -38.06%
Dec 31, 2022 -62.30%
Sep 30, 2022 -21.95%
Jun 30, 2022 -21.47%
Mar 31, 2022 -133.16%
Dec 31, 2021 -33.01%
Sep 30, 2021 -25.75%
API Access

Sonoma Pharmaceuticals Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=SNOA&period=max&api_key=YOUR_API_KEY